Make sure the single-use container is intact before use. The solution must be used immediately after opening. To avoidapossiblecontaminationofthedropperandthesolution, the dropper should not come into contact with the eye or any other surface.
Wash your hands before use.
To ensure correct administration, follow the following instructions:
1.Remove asingle-usecontainerfromthestrip.
2.Check thatthesingle-usecontainerisnotdamaged.
3.Holdthesingle-usecontainerbetweentheindexandthumbofonehand.
With the index and thumb of the other hand,performalightleveronthewingedpiecetoopenit.Donotrotatetobreakit.
4.Pullgentlytoremovethewingedpiece.
5.Lowerthecontainerslightlybelowthelowerlidtoformapouchandturnthecontainerdownwardsandpressittoapplyonedropineacheyeandblinkingafewtimes.
Do not use the single-use container again even if there is solution left.
Ifyouusemorethanonemedicationbyocularroute,theapplicationsofthedifferentmedicamentsmustbespacedatleast5minutesapart.
If you use more Carmelosa Stada than you should
You will not be harmed. If you are concerned, speak with your doctor or pharmacist.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, Teléfono 91 562 04 20, indicating the medication and the amount administered or ingested.
If you forgot to use Carmelosa Stada
Apply the next dose as needed, or following the normal schedule indicated by your doctor or pharmacist. Do not use a double dose to compensate for the missed doses.
If you have any other doubts about the use of this medication, ask your doctororpharmacist.
Like all medications, this medication may produce adverse effects, although not all people will experience them.
The adverse reactions or medically relevant adverse effects listed below have been identified in clinical trials:
Frequent Adverse Effects(may affect up to 1 in 10 patients):
Eye irritation (including burning and discomfort), eye pain, eye itching, visual disturbances.
Post-Marketing Experience
The adverse reactions or medically relevant adverse effects listed below have been reported in post-marketing experience:
Infrequent Adverse Effects(may affect up to 1 in 100 people):
Allergic reaction (including eye or eyelid inflammation), blurred vision, increased tear production (also known as epiphora), sticky eye, crust on the eyelid and/or residue of medication, eye redness/palpebral, worsening of vision, eye surface injury due to the dropper coming into contact with the eye during administration of the eye drops.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them through the Spanish System of Pharmacovigilance of Medicines for Human Use. https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information about the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after “CAD”. The expiration date is the last day of the month indicated.
Storethesingle-dosepackagingintheoriginalpackaging.
Disposeofthesingle-dosepackagingafteruse(donotre-usethepackagingonceopenedforsubsequentdoses).
Do not use this medication if you observe that the solution changes color or becomes cloudy.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the Pharmacy Take-BackPoint. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Carmelosa Stada
The components of Carmelosa Stada have been designed to simulate the natural composition of your tear.
Appearance of the product and contents of the package
CarmelosaStadaispresentedinsingle-dosecontainersof0.4mlofsterilesolution.Eachcartoncontainsonealuminumbagwith10or30single-dosecontainers.
Only some package sizes may be commercially available.
Marketing Authorization Holder
STADA, S.L.
Frederic Mompou, 5
08960 Sant Just Desvern (Barcelona)
Spain
Responsible for Manufacturing
Neuraxpharm Pharmaceuticals, S.L.
Avda. Barcelona 69
08970 Sant Joan Despí (Barcelona)
Spain
Last review date of this leaflet:January 2018
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.